369
Participants
Start Date
February 29, 2008
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
Saw Palmetto - first 24 weeks
Participants will take one 320 mg chocolate-colored soft gelcaps containing a standardized saw palmetto fruit extract for 24 weeks.
Placebo - first 24 weeks
Participants will take one 320 mg chocolate-colored soft gelcaps containing a placebo for 24 weeks.
Saw Palmetto - weeks 24 - 48
Participants will take 640 mg (2) chocolate-colored soft gelcaps containing a standardized saw palmetto fruit extract for 24 weeks.
Placebo - weeks 24 - 48
Participants will take 640 mg (2) chocolate-colored soft gelcaps containing a placebo for 24 weeks.
Saw Palmetto - weeks 48 - 72
Participants will take 960 (3) mg chocolate-colored soft gelcaps containing a standardized saw palmetto fruit extract for 24 weeks.
Placebo - weeks 48 - 72
Participants will take 960 (3) mg chocolate-colored soft gelcaps containing a placebo for 24 weeks.
New York University, New York
Cornell University, New York
University of Maryland, Baltimore
University of Texas - Southwestern Medical Center, Dallas
University of Iowa, Iowa City
Northwestern University, Chicago
Washington University, St Louis
University of Colorado, Aurora
Kaiser Permanente Division of Research, Oakland
Yale University, New Haven
Queen's University, Kingston
Collaborators (1)
Office of Dietary Supplements (ODS)
NIH
National Center for Complementary and Integrative Health (NCCIH)
NIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Cornell University
OTHER
New York University
OTHER
Kaiser Permanente
OTHER
Northwestern University
OTHER
Queen's University
OTHER
University of Colorado, Denver
OTHER
University of Iowa
OTHER
University of Maryland
OTHER
University of Texas
OTHER
Washington University School of Medicine
OTHER
Yale University
OTHER
University of Alabama at Birmingham
OTHER